Pfizer News, Corporate filings and Earnings/Conference Calls

Name: Latest research reports of Pfizer Ltd. authored by ICICI Direct and published by - Trendlyne research reports.
Item: Pfizer Ltd.
Rating: 5
Author: ICICI Direct

Keep track of all breaking news and updates on Pfizer from all sources in a single place.

Pfizer Ltd.

09 Sep 2026

4060.20

-0.86%

Novartis-Pfizer trademark deal has opposite impact on their stock prices; Novartis India jumps 20% while Pfizer slips 3%

Business Line

The two companies had announced on Monday that NIL had inked an agreement with Pfizer Inc to acquire the trademarks for India, besides certain related intellectual property rights, for 1,250 crore

Pfizer Ltd. has an average target of 5907.50 from 2 brokers.

Pfizer Ltd.

07 Sep 2026

4060.20

-0.86%

Novartis India to acquire Pfizer's 'Minipress' trademark for 1,250 crore

Business Standard

Novartis India Ltd on Monday announced that its Board of Directors has approved the acquisition of the trademarks 'Minipress' and 'Minipres' from Pfizer Inc. USA and Pfizer Products Inc. USA for a total consideration of approximately Rs 1,250 crore. In a regulatory filing, the company said the transaction involves the acquisition of the trademarks registered in India and certain related intellectual property rights for a total aggregate consideration of Rs 1,250 crore. The company has executed an asset purchase agreement and trademark assignment deeds with Pfizer Inc USA and Pfizer Products Inc USA, with the signing and closing of the transaction scheduled to occur simultaneously, as per the filing. The company noted that Minipress XL (containing prazosin) is primarily indicated in India for treating hypertension (high blood pressure) and managing the urinary symptoms of benign prostatic hyperplasia (BPH). The filing further highlighted that as per IQVIA MAT July 2026 data, Minipre

Pfizer has lost -11.92% in the last 1 Week

Pfizer Ltd.

07 Sep 2026

4060.20

-0.86%

Corp. Note

Pfizer Ltd - 500680 - Board Meeting Outcome for Discontinuation Of Minipress XL.

BSE India

Please find enclosed outcome of the Board Meeting held today i.e., September 7, 2026.

pdf

Pfizer Ltd.

04 Aug 2026

4060.20

-0.86%

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

Business Line

On an adjusted basis, the company reported a profit of 77 cents per share

Pfizer has lost -11.92% in the last 1 Week

Pfizer Ltd.

04 Aug 2026

4060.20

-0.86%

Company Update

Pfizer Ltd - 500680 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Advertisement - Special Window for Re- lodgement of Transfer and Dematerialisation of Physical Securities.

pdf

Pfizer Ltd.

29 Jul 2026

4060.20

-0.86%

AGM

Pfizer Ltd - 500680 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

BSE India

Pursuant to Regulation 44 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015, we submit herewith the consolidated Scrutinizer''s Report of the votes cast through remote e-voting and electronic polling process conducted during the 75th Annual General Meeting of the Company held on Tuesday, July 28, 2026, at 3.00 p.m. IST.

pdf

Pfizer Ltd.

29 Jul 2026

4060.20

-0.86%

Pfizer Ltd

Buy: Pfizer Ltd.

Target

ICICI Direct

Recent launches, new SKUs to drive numbers : Pfizer collectively addresses 15 therapy areas in the domestic formulations with a portfolio of more than 125 products that include therapeutics & vaccines. The company has been continuously restructuring its portfolio to...

Pfizer has lost -18.64% in the last 1 Month

Pfizer Ltd.

28 Jul 2026

4060.20

-0.86%

AGM

Pfizer Ltd - 500680 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Pursuant to Regulation 30 of SEBI LODR Regulations, 2015, please find enclosed proceedings of the 75th Annual General Meeting of the Company held on July 28, 2026.

pdf

Pfizer Ltd.

28 Jul 2026

4060.20

-0.86%

to see Rapid results content

Pfizer Ltd.

28 Jul 2026

4060.20

-0.86%

Pfizer Q1 net profit rises 7% to 204 crore, revenue reaches 653 crore

Business Standard

Revenue from operations increased 8.3 per cent to 653.17 crore, while total expenses rose 2.6 per cent to 421.33 crore in the June quarter on a year-on-year basis